Health News Editor

It’s a warm afternoon in Bozeman, and Jackie Johnston, a dedicated Democrat, is knocking on doors to discuss abortion rights in Montana. Her advocacy for protecting abortion rights is personal, driven by her daughter’s...

The Broad Institute of MIT and Harvard, known for its groundbreaking biotech research, recently made the decision to lay off 87 employees. This move comes as the institute undergoes some restructuring within its teams....

Jasper Therapeutics, a biotech company focusing on improving stem cell transplants and treating immune-mediated diseases, shared positive results from an initial clinical trial of its experimental drug for a chronic skin condition. The drug,...

Biotech investors have been showing a lot of interest in the field of autoimmune diseases this year. While the obesity market is also attracting attention, autoimmune conditions have been at the forefront of drug...

SalioGen Therapeutics, a biotech company that secured $135 million in funding to develop a cutting-edge gene-editing technology, is facing a challenging situation as it recently laid off a significant number of employees and adjusted...

Imagine a world where your elderly mother could receive quality care at home without bankrupting your family. Now picture that same world, but with a twist: The caregiver isn’t a typical home care worker,...

First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, written by biotech insiders, health care workers, researchers, and others.“To encourage robust, good-faith discussion about issues raised...

Vice President Kamala Harris has recently received a positive health report, indicating that she is in excellent health and possesses the physical and mental resilience needed to serve as president. The report was released...

Sanofi, a French drugmaker, is in talks to sell a 50% stake in its consumer health business, Opella, for $16 billion to a U.S. private equity firm. Camp4 Therapeutics raised $75 million in an...

Pharmalot Columnist, Senior WriterHave you recently hired a new and exciting employee? Promoted a rising star within your company? Finally filled a challenging position? Don't keep it to yourself - share the news with...

John Maraganore, a well-known figure in the biotech industry, recently discussed his involvement in the innovative RNAi startup, City Therapeutics, on the latest episode of STAT's biotech podcast, "The Readout LOUD." Maraganore shared insights...

Bill Nye, best known as the Science Guy, has shifted his focus to bring attention to ataxia, a neurological disease that has impacted his family for generations. He has teamed up with the National...